Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ziva Pohar-Marinsek"'
Autor:
Nika Kotnik, Veronika Kloboves Prevodnik, Urška Ivanuš, Ziva Pohar Marinsek, Tine Jerman, Jerneja Varl, Hermina Rozina, Janja Zalar
Publikováno v:
Radiology and Oncology, Vol 54, Iss 2, Pp 201-208 (2020)
Radiology and Oncology
Radiology and Oncology
Background p16/Ki-67 dual immunocytochemical staining (DS) is considered easy to interpret if evaluators are properly trained, however, there is no consensus on what constitutes proper training. In the present study we evaluated a protocol for teachi
Autor:
Anja Oštrbenk Valenčak, Tine Jerman, Jerneja Varl, Urška Ivanuš, Ziva Pohar Marinsek, Mario Poljak, Veronika Kloboves Prevodnik
Publikováno v:
Radiology and Oncology, Vol 53, Iss 3, Pp 316-322 (2019)
Radiology and Oncology
Radiology and Oncology
Background The Hybrid Capture 2 (HC2) High-Risk HPV DNA assay serves as a triage test in the Slovenian national cervical cancer screening programme ZORA. To improve the limited analytical accuracy of HC2 test results near the cut-off value (1.0 relat
Publikováno v:
International Journal of Molecular Sciences
Volume 20
Issue 11
International Journal of Molecular Sciences, Vol 20, Iss 11, p 2648 (2019)
Volume 20
Issue 11
International Journal of Molecular Sciences, Vol 20, Iss 11, p 2648 (2019)
Flow cytometry is helpful in differentiating between B-cell lymphoma (BCL) and reactive lymphocytic proliferation (RLP) in FNA biopsies. However
the presence of inconclusive surface immunoglobulin light chains (sIg LC) poses a problem. We invest
the presence of inconclusive surface immunoglobulin light chains (sIg LC) poses a problem. We invest
Autor:
Andreja Gornjec, Erik Škof, Marko Hočevar, Vida Stegel, Barbara Gazic, Ziva Pohar Marinsek, Srdjan Novaković, Mateja Krajc
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Background High-grade serous ovarian cancer is a detrimental disease. Treatment options in patients with a recurrent disease are dependent on BRCA1/2 mutation status since only patients with known BRCA mutation are eligible for treatment with poly(AD
This richly illustrated book will help presurgically diagnose pediatric/young adult tumors. The content is divided into two parts. The first part shows step-by-step how to perform a small volume specimen such as fine needle aspiration/core needle bio
Publikováno v:
Diagnostic Pathology
Background Flow cytometric immunophenotyping (FCI), is widely used in cytology for distinguishing between B-cell lymphoma (BCL) and reactive lymphocytic proliferations (RLP), mainly by identifying monotypic B-cell populations. Since this cannot alway
Publikováno v:
Pediatric Hematology and Oncology. 23:355-367
The study includes 91 patients treated for Ewing sarcoma between 1972 and 2002. Forty were younger and 51 were older than 16. The overall 5-year survival was 36%: 53.5% in the younger and 22.5% in the older age group. Among patients with localized di
Publikováno v:
Medical and Pediatric Oncology. 38:416-420
Background Chemotherapy (Cht) for rhabdomyosarcoma (RMS) given before local treatment can prevent mutilating surgery and high-dose irradiation (RT). Fine needle aspiration biopsy (FNAB) can confirm the diagnosis and neoadjuvant treatment can start wi
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 15(8)
The expressions of different markers have been immunohistochemically studied in various types of the Ewing's sarcoma family of tumors, especially for diagnostic purposes. However, little is known about their prognostic value in combination with the c